FEATURED EDITORIAL
On January 26th, 2026 as we celebrate this centennial milestone of Schrödinger’s Equation, it’s worth asking: What does quantum mechanics mean for drug discovery and biomolecular simulations?
- The FXI Gamble: To Bleed Less... Or To Protect Less?
- Hibernating Squirrels May Hold Clues To Treating Heart Failure
- Engineering Therapeutics With A Structural Approach
- Room For Improvement: Reformulating Existing Therapeutics
- Harnessing Mitochondria: A New Frontier In Therapeutic Innovation
- The Unlikely Weapon Against Fentanyl: Your Immune System
- Partnering For Progress: Funding The Future Of Rare Disease Research
FEATURED APPLICATION CONTENT
-
Discover how mixed-mode chromatography enables high-yield purification of single-domain antibodies under mild conditions and why these approaches outperform traditional resins.
-
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Decoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.
-
Explore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.
-
Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
Explore how a modular AAV8 platform enables scalable, GMP-ready gene therapy manufacturing with reproducible outcomes, streamlined tech transfer, and adaptability across serotypes.
-
Discover how a CDMO achieved 40x productivity and 15% cost savings by switching to rapid cycling membrane chromatography for ADC polishing, which helped cut process time and buffer use.
-
Continuous biomanufacturing is reshaping how active pharmaceutical ingredients are produced. Learn how modular, automated virus inactivation solutions are helping manufacturers improve efficiency.
-
Explore how digital tools are advancing peptide purification, with a focus on GLP-1 receptor agonists, as well as how process efficiency can be accelerated through real-time insights.
-
Gain insight into how consolidating downstream operations into a single automated system can reduce footprint, cut processing time, and minimize manual errors to help teams work more efficiently.
-
Explore a scalable AAV production platform that improves full capsid yield and dramatically reduces host cell impurities, offering a practical solution to common manufacturing challenges.
-
Discover scalable strategies for overcoming AAV purification challenges, from low yield and impurity removal to serotype variability, as well as how advanced tools can streamline manufacturing.
- Schrödinger's Equation Turns 100: How Quantum Chemistry Is Improving Drug Discovery
- Annual Reflections And Predictions From The Editors' Roundtable
- The Unlikely Weapon Against Fentanyl: Your Immune System
- 2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026
- GO‑4 Drug Combo Offers New Hope for Treating Late-Stage BRCA/PALB2-Mutated Cancers
FEATURED NEWS HEADLINES
- FAR Biotech Officially Establishes Wisconsin Presence, Expanding Its QuantumAI Drug Discovery Programs In Madison
- Chinese NMPA Accepts New Drug Application For Illuccix For Prostate Cancer Imaging
- Rein Therapeutics Receives Orphan Drug Designation From European Medicines Agency For Lead Drug Candidate In Idiopathic Pulmonary Fibrosis
- Cogent Biosciences To Initiate New Drug Application (NDA) Submission For Bezuclastinib Under Real-Time Oncology Review (RTOR)
- Celcuity Announces FDA Acceptance Of New Drug Application For Gedatolisib In HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
- SandboxAQ Supercharges OpenFold3 With AQAffinity: High-Speed, Structure-Free Drug Potency Prediction
- Abcam Joins The Innovative Health Initiative LIGAND-AI Project To Advance Artificial Intelligence (AI)-Driven Drug Discovery Through Open Science
- Lantern Pharma's LP-284 Receives FDA Orphan Drug Designation For Soft Tissue Sarcomas
- Using AI To Accelerate Drug Development
- Organon Announces US Food And Drug Administration Approval Of Supplemental New Drug Application Extending Duration Of Use Of NEXPLANON (etonogestrel implant) 68 mg Radiopaque
ARCHIVED NEWSLETTER
- 01.20.26 -- CROs In Early Drug Discovery, Part 1: Choosing The Right Partner
- 01.13.26 -- Reflections And Predictions From The Editors' Roundtable
- 01.06.26 -- The Unlikely Weapon Against Fentanyl: Your Immune System
- 12.23.25 -- 2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026
- 12.16.25 -- Returning To Nature: Discovering The Next Generation Of Medicines